Serum HLA-G Levels in Kidney Transplant Recipients and Association With Clinical Outcomes: A Single-Center Cross-Sectional Study
Transplantation Proceedings · 2026
DOI: 10.1016/j.transproceed.2026.04.015 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Transplantation Proceedings, 2026. Verfasst von Silvia Marçal Botelho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Goiás - Faculdade de Medicina, Departamento de Clínica Médica, Goiânia, Goiás, Brazil; Santa Casa de Goiânia - Kidney Transpl…. Hauptthemen laut MEDLINE: Kidney Transplantation, HLA-G Antigens. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: HLA-G is a non-classical HLA class I molecule with immunomodulatory properties and has been proposed as a biomarker of immune tolerance in kidney transplantation. However, the clinical meaning of circulating HLA-G remains controversial. METHODS: We conducted a cross-sectional, single-center study including kidney transplant recipients with available clinical data and serum samples. Soluble HLA-G levels were quantified by enzyme-linked immunosorbent assay. We tested associations between HLA-G levels and immunosuppressive regimen, acute rejection episodes, cytomegalovirus (CMV) infection, and early post-transplant need for hemodialysis. Statistical significance was defined as P < .05. RESULTS: A total of 114 kidney transplant recipients were analyzed. Use of a regimen including corticosteroids, a calcineurin inhibitor, and azathioprine was associated with lower HLA-G levels (P < .001). Lower HLA-G levels were also associated with acute rejection (P < .001) and CMV infection (P = .006). In contrast, recipients requiring 6-10 hemodialysis sessions in the early post-transplant period showed higher HLA-G levels (P = .02). CONCLUSIONS: Serum HLA-G levels were significantly associated with clinically relevant outcomes after kidney transplantation. Lower HLA-G levels were linked to acute rejection and CMV infection, whereas higher HLA-G levels were observed among recipients requiring more hemodialysis early after transplantation. These findings support further evaluation of HLA-G as a prognostic biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Universidade Federal de Goiás - Faculdade de Medicina, Departamento de Clínica Médica, Goiânia, Goiás, Brazil; Santa Casa de Goiânia - Kidney Transplant Unit, Goiânia, Goiás, Brazil; Pontifícia Universidade Católica de…
- Pontifícia Universidade Católica de Goiás - Escola de Ciências Médicas e da Vida, School of Medicine, Nephrology Discipline, Goiânia, Goiás, Brazil.
- Universidade Estadual de Goiás - Laboratory of Molecular Immunology, Goiás, Brazil.
- Universidade Federal de Goiás - Faculdade de Medicina, Departamento de Clínica Médica, Goiânia, Goiás, Brazil; Pontifícia Universidade Católica de Goiás - Escola de Ciências Médicas e da Vida, School of Medicine, Nephro…
Zitieren
APA
Botelho, S. M., Chaves, G. M. N. A., Wastowski, I. J., & da Silva Júnior, A. M. (2026). Serum HLA-G Levels in Kidney Transplant Recipients and Association With Clinical Outcomes: A Single-Center Cross-Sectional Study. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2026.04.015
Vancouver
Botelho SM, Chaves GMNA, Wastowski IJ, da Silva Júnior AM. Serum HLA-G Levels in Kidney Transplant Recipients and Association With Clinical Outcomes: A Single-Center Cross-Sectional Study. Transplantation Proceedings. 2026. doi:10.1016/j.transproceed.2026.04.015
BibTeX
@article{Botelho2026,
author = {Botelho, Silvia Marçal and Chaves, Geovana Maria Nunes Arantes and Wastowski, Isabela Jubé and da Silva Júnior, Antônio Menezes},
title = {Serum HLA-G Levels in Kidney Transplant Recipients and Association With Clinical Outcomes: A Single-Center Cross-Sectional Study},
journal = {Transplantation Proceedings},
year = {2026},
doi = {10.1016/j.transproceed.2026.04.015}
}
EUVIMED